Retevmo Capsule: Indian Suppliers and Manufacturing
Retevmo (selpercatinib) is an oral medication used to treat certain types of cancer, including thyroid cancer and non-small cell lung cancer [1]. While the drug is manufactured by Eli Lilly and Company, its supply chain can involve various entities, including those in India. Companies in India may be involved in the manufacturing of active pharmaceutical ingredients (APIs) or finished dosage forms, or they may act as distributors [2].
How is Retevmo Supplied?
Retevmo is supplied as capsules in several dosage strengths [1]. The specific packaging and presentation are determined by the manufacturer.
Who Makes Retevmo?
Retevmo is developed and manufactured by Eli Lilly and Company [1].
When Could Generic Retevmo Be Available?
The availability of generic versions of Retevmo depends on patent expirations and any potential market exclusivity periods. Patent information for drugs like Retevmo is tracked by entities such as DrugPatentWatch.com [3]. Generally, generic entry can only occur after patents protecting the drug expire, unless specific legal challenges or agreements allow for earlier market access.
What is the Active Ingredient in Retevmo?
The active ingredient in Retevmo capsules is selpercatinib [1].
How Does Retevmo Work?
Selpercatinib is a kinase inhibitor that targets RET (Rearranged during Transfection) fusions and mutations [1]. By inhibiting these specific genetic alterations, it helps to stop cancer cell growth and proliferation.
Where Can I Find Information on Retevmo Patents?
Information regarding patents for drugs like Retevmo can be found on specialized patent databases and websites that track pharmaceutical intellectual property. DrugPatentWatch.com is a resource that provides data on drug patents [3].
Sources
1. Eli Lilly and Company. Retevmo Prescribing Information.
2. Pharmaceutical Technology. (n.d.). India.
3. DrugPatentWatch.com.